drugset / Trial / NCT00892567
Evaluating the T Cell Response to a Peptide-based Vaccine in Patients With Breast Cancer
NaSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to evaluate T cell responses against a peptide-based vaccine in patients with breast cancer and to determine whether peptide-specific T cells can be found at the site of breast tumors following vaccination.
Timeline
- Start
- 2009-05
- Primary completion
- 2011-12
- Completion
- 2012-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | 9 Peptides from Her-2/neu, CEA, & CTA | Vaccine | 1 ml | Subcutaneous |